COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,659 Articles (22,913 medRxiv, 8,746 bioRxiv)

Most recent first Previous |  Page 1430: Articles 14291-14300  | Next

Multivalent designed proteins protect against SARS-CoV-2 variants of concern
Hunt, A. C., Case, J. B., Park, Y.-J., Cao, L., Wu, K., Walls, A. C., Liu, Z., Bowen, J. E., Yeh, H.-W., Saini, S., Helms, L., Zhao, Y. T., Hsiang, T.-Y., Starr, T. N., Goreshnik, I., Kozodoy, L., Carter, L., Ravichandran, R., Green, L. B., Matochko, W. L., Thomson, C. A., Vogeli, B., Kruger-Gericke, A., VanBlargan, L. A., Chen, R. E., Ying, B., Bailey, A. L., Kafai, N. M., Boyken, S., Ljubetic, A., Edman, N., Ueda, G., Chow, C., Addetia, A., Panpradist, N., Gale, M., Freedman, B., Lutz, B., Bloom, J. D., Ruohola-Baker, H., Whelan, S. P. J., Stewart, L., Diamond, M. S., Veesler, D., Jewett, M. C., Baker, D.
10.1101/2021.07.07.451375 — Posted: 2021-07-07
CAT, AGTR2, L-SIGN and DC-SIGN are potential receptors for the entry of SARS-CoV-2 into human cells
Guo, D., Guo, R., Li, Z., Zhang, Y., Zheng, W., Huang, X., Aziz, T., Zhang, Y., Liu, L.
10.1101/2021.07.07.451411 — Posted: 2021-07-07
Receptor-binding domain recombinant protein RBD219-N1C1 on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
Pollet, J., Strych, U., Chen, W.-H., Versteeg, L., Keegan, B., Zhan, B., Wei, J., Liu, Z., Lee, J., Kundu, R., Adhikari, R., Poveda, C., Villar, M. J., Lopez, B., Gillespie, P. M., Ronca, S., Kimata, J. T., Reers, M., Paradkar, V., Hotez, P., Bottazzi, M. E.
10.1101/2021.07.06.451353 — Posted: 2021-07-07
Immunogenicity of low dose prime-boost vaccination of mRNA vaccine CV07050101 in non-human primates
van Doremalen, N., Fischer, R., Schulz, J., Holbrook, M., Smith, B., Lovaglio, J., Petsch, B., Munster, V.
10.1101/2021.07.07.451505 — Posted: 2021-07-07
Defining the Immune Responses for SARS-CoV-2-Human Macrophage Interactions
Mostafa, M., Yeapuri, P., Machhi, J., Olson, K., Shahjin, F., Zhou, Y., Jingjing, L., Pandey, K., Acharya, A., Byrareddy, S., Mosley, L., Gendelman, H.
10.1101/2021.07.07.449660 — Posted: 2021-07-07
Effectiveness of Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 Patients
Hazan, S., Dave, S., Gunaratne, A. W., Dolai, S., McCullough, P. A., Clancy, R., Borody, T. J.
10.1101/2021.07.06.21259924 — Posted: 2021-07-07 Discussion: Onsite | Offsite
Evaluation of Clinical Job Demands, Job Resources, and a Novel Intervention on Measures of Health Care Worker Stress at a Community Hospital Pre and Post COVID-19
Sels, J., Carroll, D., Duffee, D.
10.1101/2021.07.06.21260093 — Posted: 2021-07-07
Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors
Uyoga, S., Adetifa, I. M. O., Otiende, M., Gitonga, J., Mugo, D., Nyagwange, J., Karanja, H. K., Tuju, J., Makale, J., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., Ng'ang'a, W., Kilonzo, N., Chege, E., Yegon, C., Odhiambo, E., Rotich, T., Orgut, I., Kihara, S., Bottomley, C., Kagucia, E. W., Gallagher, K., Etyang, A. O., Voller, S., Lambe, T., Wright, D., Barasa, E., Tsofa, B., Mwangangi, J., Bejon, P., Ochola-Oyier, L. I., Warimwe, G. M., Agweyu, A., Scott, J. A. G.
10.1101/2021.07.06.21260038 — Posted: 2021-07-07
Untargeted saliva metabolomics reveals COVID-19 severity: Saliva Metabolomics for SARS-COV-2 Prognosis
Bailey, M., Spick, M. P., Longman, K., Frampas, C., Lewis, H. M., Costa, C. D., Stewart, A., Dunn-Walters, D., Skene, D., Greener, D., Evetts, G. E., Trivedi, D. K., Barran, P., Pitt, A., Hollywood, K.
10.1101/2021.07.06.21260080 — Posted: 2021-07-07
Next-generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire
Melani, R. D., Des Soye, B. J., Kafader, J. O., Forte, E., Hollas, M., Blagovich, V., Negrao, F., McGee, J. P., Drown, B., Lloyd-Jones, C., Seckler, H. S., Camarillo, J. M., Compton, P. D., LeDuc, R. D., Early, B., Fellers, R. T., Cho, B.-K., Baby Mattamana, B., Goo, Y. A., Thomas, P. M., Ash, M. K., Bhimalli, P. P., Al-Harthi, L., Sha, B. E., Schneider, J. R., Kelleher, N. L.
10.1101/2021.07.06.21259226 — Posted: 2021-07-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).